ArticleClinical interventions in aging2025

Real-World Comparative Study of Ultra-Low-Dose Rivaroxaban in Very Elderly Patients with Atrial Fibrillation.

Dan Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.